Menu Menu

AUPH    Aurinia Pharmaceuticals Inc    1600620    
Income Statement
Revenue 59,867,000
Net Income 1,429,000
Profit Margin 2.39%

Balance Sheet
Current Assets 446,596,000
Assets 550,645,000
Current Liabilities 97,763,000
Liabilities 173,167,000
Equity 377,478,000
Shares Out 142,991,000

Cash Flow Statement
Operating Cash Flow 44,388,000
Investing Cash Flow 39,262,000

Market Analysis
Market Cap 1,030,965,115
Price 8.40
BVPS 2.64
PB 3.13
EPS -0.35
PS 4.31
FCF 83,650,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/27 0.01
Apr May Jun
5/02 -0.07
Jul Aug Sep
8/01 0.01
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view AUPH documents filed with the SEC.


AUPH Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: